Insider sale
ATTOVIA THERAPEUTICS, INC.
$2.22M
105.81K shares
What this filing means
GOLDMAN SACHS GROUP INC plans to sell 105.81K shares of ATTOVIA THERAPEUTICS, INC. valued at approximately $2.22M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/28/2026ACC: 0000891836-26-000065
10% Owner
Since Aug 2026
105.81K
Shares to sell
$2.22M
Approx. market value
105.81K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
See Remarks (2)
N/A
8/5/2026
105.81KTotal acquired105.81K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/5/2026 | See Remarks (2) N/A | 105.81K | — |
| Total | 105.81K | ||
Planned & Completed Dispositions1
See Remarks (1)Planned
Units to sell
105.81K
Market value
$2.22M
8/5/2026
Total
Units
105.81K
Value
$2.22M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
8/5/2026 | 105.81K | $2.22M | See Remarks (1) | Planned |
| Total | 105.81K | $2.22M | ||